Q32 Bio (QTTB) Stock Research

Over a week ago

Q32 Bio price target raised by $23 at H.C. Wainwright, here's why

QTTB

Jul 28, 5:59 AM

Q32 Bio files to sell 6.88M shares of common stock for holders

QTTB

Jul 17, 4:15 PM

Q32 Bio 6.03M share secondary priced at $18.25

QTTB

Jul 14, 11:03 PM

What You Missed On Wall Street On Monday

+27

Jul 13, 4:25 PM

Q32 Bio announces $200M common stock offering

QTTB

Jul 13, 4:06 PM

Q32 Bio price target raised by $22 at Mizuho, here's why

QTTB

Jul 13, 2:10 PM

Midday Fly By: Apple sues OpenAI, MGM in talks with Diller's People

+29

Jul 13, 11:58 AM

Q32 Bio upgraded to Overweight at Wells Fargo after alopecia areata study data

QTTB

Jul 13, 9:37 AM

Q32 Bio price target raised by $20 at Oppenheimer, here's why

QTTB

Jul 13, 9:36 AM

Wells Fargo gets more bullish on Q32 Bio, upgrades shares

QTTB

Jul 13, 9:34 AM

Q32 Bio reports 36-week topline results from Part B of the SIGNAL-AA trial

QTTB

Jul 13, 7:07 AM

Q32 Bio files $300M mixed securities shelf

QTTB

Jun 25, 4:15 PM

Five new option listings and two option delistings on June 24th

Jun 24, 8:30 AM

Q32 Bio Inc trading resumes

QTTB

May 27, 9:37 AM

Q32 Bio Inc trading halted, volatility trading pause

QTTB

May 27, 9:32 AM

Q32 Bio announces $55M private placement

QTTB

May 27, 8:02 AM

Q32 Bio initiated with bullish view at Mizuho, here's why

QTTB

May 22, 4:33 AM

Q32 Bio initiated with bullish view at Cantor Fitzgerald

QTTB

May 18, 6:49 AM

Q32 Bio initiated with bullish view at H.C. Wainwright, here's why

QTTB

Feb 25, 6:05 AM

Q32 Bio announces $10.5M registered direct offering

QTTB

Feb 17, 7:04 AM

Akebia Therapeutics announces establishment of rare kidney disease pipeline

Dec 1, 7:15 AM

Q32 Bio sells complement inhibitor ADX-097 to Akebia for $12M upfront

Dec 1, 7:05 AM

Q32 Bio reports Q3 EPS (60c), consensus ($1.19)

QTTB

Nov 13, 7:00 AM

Q32 Bio completes enrollment in Part B of SIGNAL-AA trial

QTTB

Oct 21, 7:08 AM

Eight option delistings on August 18th

Aug 18, 8:30 AM